Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
China
· Delayed Price · Currency is CNY 14.11
+0.07 (0.50%)
May 14, 2025, 9:45 AM CST
SHE:300601 Revenue
Shenzhen Kangtai Biological Products had revenue of 645.20M CNY in the quarter ending March 31, 2025, with 42.85% growth. This brings the company's revenue in the last twelve months to 2.85B, down -10.55% year-over-year. In the year 2024, Shenzhen Kangtai Biological Products had annual revenue of 2.65B, down -23.75%.
Revenue (ttm)
2.85B
Revenue Growth
-10.55%
P/S Ratio
5.60
Revenue / Employee
1.49M
Employees
1,913
Market Cap
15.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.65B | -825.72M | -23.75% |
| Dec 31, 2023 | 3.48B | 320.04M | 10.14% |
| Jan 1, 2023 | 3.16B | -494.69M | -13.55% |
| Jan 1, 2022 | 3.65B | 1.39B | 61.51% |
| Dec 31, 2020 | 2.26B | 317.85M | 16.36% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |